Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Am J Transplant. 2020 Mar 12;20(9):2559–2566. doi: 10.1111/ajt.15830

Table 2.

Multivariable Poisson regression evaluating the association between the number of organs transplanted per donor and (a) MDRO or (b) MDR-GN on donor hospital cultures

A. Any MDROa B. MDR-GNb
Donor variable IRR 95% CI P value Donor variable IRR 95% CI P value
MDRO on culture 1.15 0.99–1.33 0.068 MDR-GN on culture 0.43 0.39–0.48 <0.001
DCD 0.44 0.37–0.52 <0.001 Albumin 1.03 1.03–1.04 <0.001
ECD 0.70 0.57–0.86 0.001 DCD 0.44 0.37–0.53 <0.001
HCV seropositive 0.50 0.39–0.64 <0.001 ECD 0.65 0.52–0.81 <0.001
Albumin 1.04 1.03–1.05 <0.001 KDPI 0.99 0.992–0.996 <0.001
KDPI 0.996 0.994–0.997 <0.001 HCV seropositive 0.47 0.35–0.61 <0.001
ECMO 0.67 0.52–0.85 0.001 ECMO 0.64 0.49–0.85 0.002
Open abdomen 0.81 0.69–0.97 0.019 Open abdomen 0.77 0.65–0.92 0.003
Diabetes mellitus 0.63 0.47–0.84 0.002 Death due to cardiovascular cause 0.85 0.77–0.94 0.002
Death due to cardiovascular cause 0.85 0.77–0.94 0.001 Intra-aortic balloon pump 0.69 0.58–0.82 <0.001
Death due to gunshot wound 1.16 1.03–1.31 0.018 Confounders/Interaction terms
Confounders LRTI 0.90 0.82–0.98 0.019
Length of stay 1.00 0.994–1.01 0.990 MDR-GN by LRTI interaction term 2.31 1.66–3.23 <0.001
Age 0.999 0.997–1.003 0.996
a

The comparator group in this analysis was comprised of those donors with no MDROs on culture (which could include donors with no positive cultures or those with non-MDRO positive cultures).

b

The comparator group in this analysis was comprised of those donors with no MDR-GNs on cultures (which could include donors with no positive cultures, those with non-MDRO positive cultures, or those with an MDR-GP on culture).

Abbreviations: CI, confidence interval; DCD, donation after circulatory death; ECD, expanded criteria donor; ECMO, extracorporeal membrane oxygenation; HCV, hepatitis C virus; IRR, incidence rate ratio; KDPI, Kidney Donor Profile Index; MDR-GN, multidrug-resistant Gram-negative; MDRO, multidrug-resistant organism; LRTI, lower respiratory tract infection